Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Insulin, Glulisine, Human

Known as: insulin, Lys(B3)-Glu(B29)-, glulisine insulin, INSULIN GLULISINE 
A drug used to control the amount of sugar in the blood of patients with diabetes mellitus. It is a form of the hormone insulin that is made in the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
OBJECTIVE To provide evidence-based options on how to intensify basal insulin, we explored head-to-head prandial interventions in… Expand
  • table 1
  • table 2
  • figure 1
  • figure 1
  • table 3
Highly Cited
2013
Highly Cited
2013
OBJECTIVE Effective and easily implemented insulin regimens are needed to facilitate hospital glycemic control in general medical… Expand
  • figure 1
  • table 1
  • table 2
Highly Cited
2012
Highly Cited
2012
OBJECTIVE Renal insufficiency may increase the risk of hypoglycemia in hospitalized patients with diabetes who are treated with… Expand
  • table 1
  • figure 2
  • figure 1
Highly Cited
2011
Highly Cited
2011
Aim: Stepwise intensification of insulin treatment to match the progressive decline of endogenous insulin secretion has been… Expand
Highly Cited
2010
Highly Cited
2010
Aims/hypothesisFive insulin analogues, with modified insulin-like molecular structures, are currently approved for treating… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2010
Highly Cited
2010
OBJECTIVE We tested the hypothesis that an increase in insulin per se, i.e., in the absence of zinc, suppresses glucagon… Expand
  • figure 1
  • figure 2
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To compare the safety and efficacy of insulin analogs and human insulins both during acute intravenous treatment and… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
Review
2008
Review
2008
Insulin glulisine injection [3B-Lys, 29B-Glu-human insulin] is the newest human insulin analogue product for the control of… Expand
Highly Cited
2008
Highly Cited
2008
Aim:  To investigate whether the addition of a single bolus of insulin glulisine (glulisine), administered at either breakfast or… Expand
Highly Cited
2005
Highly Cited
2005
OBJECTIVE To compare the efficacy and safety of insulin glulisine (GLU), a new rapid-acting insulin analogue, injected 0 to 15… Expand